Insider Transactions in Q4 2025 at Moon Lake Immunotherapeutics (MLTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 19
2025
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
196,316
-100.0%
|
-
|
|
Dec 19
2025
|
Da Silva Jorge Santos Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
196,316
+6.0%
|
-
|
|
Dec 19
2025
|
Kristian Reich Chief Scientific Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,389
-100.0%
|
-
|
|
Dec 19
2025
|
Kristian Reich Chief Scientific Officer |
BUY
Conversion of derivative security
|
Direct |
35,389
+50.0%
|
-
|
|
Dec 19
2025
|
Matthias Bodenstedt Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
294,473
-100.0%
|
-
|
|
Dec 19
2025
|
Matthias Bodenstedt Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
294,473
+24.21%
|
-
|
|
Dec 09
2025
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
70,000
-2.37%
|
$980,000
$14.49 P/Share
|
|
Dec 09
2025
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
72,908
-100.0%
|
$1,020,712
$14.43 P/Share
|
|
Dec 08
2025
|
Da Silva Jorge Santos Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
130,000
-4.22%
|
$1,950,000
$15.08 P/Share
|
|
Dec 08
2025
|
Kristian Reich Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
130,000
-64.07%
|
$1,950,000
$15.08 P/Share
|
|
Oct 08
2025
|
Matthias Bodenstedt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,870
+1.7%
|
$97,830
$9.09 P/Share
|